AbsEn.i
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « regarding »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
regarded < regarding < regardless  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
000003 (2020) Charlotte Girard-Guyonvarc'H ; Michele Iudici[Targeted therapies for connective tissue diseases and vasculitis].
000006 (2020) Anna Jakubczyc ; Claus Neurohr[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000020 (2020) Jared Radbel [États-Unis] ; Navaneeth Narayanan [États-Unis] ; Pinki J. Bhatt [États-Unis]Use of tocilizumab for COVID-19 infection-induced cytokine release syndrome: A cautionary case report.
000082 (2020) Eun-Jung Park [Corée du Sud] ; Hyungjin Kim [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Yoon-Kyoung Sung [Corée du Sud] ; Han Joo Baek [Corée du Sud] ; Jisoo Lee [Corée du Sud]The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
000169 (2020) Maria Antonietta Barbieri [Italie] ; Giuseppe Cicala [Italie] ; Paola Maria Cutroneo [Italie] ; Elisabetta Gerratana [Italie] ; Caterina Palleria [Italie] ; Caterina De Sarro [Italie] ; Ada Vero [Italie] ; Luigi Iannone [Italie] ; Antonia Manti [Italie] ; Emilio Russo [Italie] ; Giovambattista De Sarro [Italie] ; Fabiola Atzeni [Italie] ; Edoardo Spina [Italie]Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study.
000218 (2020) Piero Ruscitti [Italie] ; Paola Cipriani [Italie] ; Vasiliki Liakouli [Italie] ; Daniela Iacono [Italie] ; Ilenia Pantano [Italie] ; Francesco Caso [Italie] ; Federico Perosa [Italie] ; Fabiola Atzeni [Italie] ; Francesco Paolo Cantatore [Italie] ; Raffaele Scarpa [Italie] ; Francesco Ciccia [Italie] ; Roberto Giacomelli [Italie]Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
000235 (2020) Nikita Mehta [États-Unis] ; Maryann Mazer-Amirshahi [États-Unis] ; Nour Alkindi [États-Unis]Pharmacotherapy in COVID-19; A narrative review for emergency providers
000236 (2020) Laure Elens [Belgique] ; Loralie J. Langman [États-Unis] ; Dennis A. Hesselink ; Stein Bergan [Norvège] ; Dirk Jan A. R. Moes ; Mariadelfina Molinaro [Italie] ; Raman Venkataramanan [États-Unis] ; Florian Lemaitre [France]Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions
000268 (2020) Muhammad Khan [République populaire de Chine] ; Sumbal Arooj [Pakistan] ; Hua Wang [République populaire de Chine]NK Cell-Based Immune Checkpoint Inhibition
000292 (2020) Fujun Peng [République populaire de Chine] ; Lei Tu [République populaire de Chine] ; Yongshi Yang [République populaire de Chine] ; Peng Hu [République populaire de Chine] ; Runsheng Wang [République populaire de Chine] ; Qinyong Hu [République populaire de Chine] ; Feng Cao [République populaire de Chine] ; Taijiao Jiang [République populaire de Chine] ; Jinlyu Sun [République populaire de Chine] ; Guogang Xu [République populaire de Chine] ; Christopher Chang [États-Unis]Management and Treatment of COVID-19: The Chinese Experience
000296 (2020) Mayan Gilboa [Israël] ; Gil Bornstein [Israël] ; Ilan Ben-Zvi [Israël] ; Chagai Grossman [Israël]Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review.
000297 (2020) Jie Xiao [République populaire de Chine] ; Tian Wang [République populaire de Chine] ; Yi Xu [République populaire de Chine] ; Xiaozhen Gu [République populaire de Chine] ; Danyang Li [République populaire de Chine] ; Kang Niu [République populaire de Chine] ; Tiandong Wang [République populaire de Chine] ; Jing Zhao [République populaire de Chine] ; Ruiqing Zhou [République populaire de Chine] ; Hui-Li Wang [République populaire de Chine]Long-term probiotic intervention mitigates memory dysfunction through a novel H3K27me3-based mechanism in lead-exposed rats
000302 (2020) Adriana Balduzzi [Italie] ; Erica Brivio [Italie, Pays-Bas] ; Attilio Rovelli [Italie] ; Carmelo Rizzari [Italie] ; Serena Gasperini [Italie] ; Maria Luisa Melzi [Italie] ; Valentino Conter [Italie] ; Andrea Biondi [Italie]Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati
000309 (2020) Florian Moretto ; François-Xavier Catherine ; Clémentine Esteve ; Mathieu Blot [France] ; Lionel Piroth [France]Isolated Anti-HBc: Significance and Management
000399 (2020) Gregorio Tersalvi [Suisse] ; Marco Vicenzi [Italie] ; Davide Calabretta [Italie] ; Luigi Biasco [Italie, Suisse] ; Giovanni Pedrazzini [Suisse] ; Dario Winterton [Italie]Elevated troponin in patients with Coronavirus Disease 2019 (COVID-19): possible mechanisms
000474 (2020) Monica S. Thakar [États-Unis] ; Tyce J. Kearl [États-Unis] ; Subramaniam Malarkannan [États-Unis]Controlling Cytokine Release Syndrome to Harness the Full Potential of CAR-Based Cellular Therapy
000493 (2020) Alessandro Allegra ; Caterina Musolino ; Alessandro Tonacci ; Giovanni Pioggia ; Marco Casciaro ; Sebastiano GangemiClinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role
000506 (2020) Awadhesh Kumar Singh [Inde] ; Akriti Singh [Inde] ; Altamash Shaikh [Inde] ; Ritu Singh [Inde] ; Anoop Misra [Inde]Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries
000512 (2020) Veronika Bachanova [États-Unis] ; Michael R. Bishop [États-Unis] ; Parastoo Dahi [États-Unis] ; Bhagirathbhai Dholaria [États-Unis] ; Stephan A. Grupp [États-Unis] ; Brandon Hayes-Lattin [États-Unis] ; Murali Janakiram [États-Unis] ; Richard T. Maziarz [États-Unis] ; Joseph P. Mcguirk [États-Unis] ; Loretta J. Nastoupil [États-Unis] ; Olalekan O. Oluwole [États-Unis] ; Miguel-Angel Perales [États-Unis] ; David L. Porter [États-Unis] ; Peter A. Riedell [États-Unis]Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic.
000513 (2020) Florence A. Aeschlimann [France, Suisse] ; Marinka Twilt [Canada] ; Rae S. M. Yeung [Canada]Childhood-onset Takayasu Arteritis
000514 (2020) Fatih Ha Lak [Turquie] ; Mehmet Y Ld Z [Turquie] ; Amra Adrovic [Turquie] ; Kenan Barut [Turquie] ; Özgür Kasapçopur [Turquie]Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "regarding" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "regarding" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    regarding
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021